Taniborbactam

他尼硼巴坦

Report date: 2024/07/09 15:59:45
NME

Base Information

Drug NameTaniborbactam
Drug Alias Name他尼伯巴坦VNRX-5133
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesVenatorx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A